摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-3-isobutyl-5-(3-(2-nitrophenyl)acryloyl)-3-phenyl-4,5,6,7-tetrahydrofuro[3,4-c]pyridin-1(3H)-one | 1443251-03-3

中文名称
——
中文别名
——
英文名称
(E)-3-isobutyl-5-(3-(2-nitrophenyl)acryloyl)-3-phenyl-4,5,6,7-tetrahydrofuro[3,4-c]pyridin-1(3H)-one
英文别名
3-(2-methylpropyl)-5-[(E)-3-(2-nitrophenyl)prop-2-enoyl]-3-phenyl-6,7-dihydro-4H-furo[3,4-c]pyridin-1-one
(E)-3-isobutyl-5-(3-(2-nitrophenyl)acryloyl)-3-phenyl-4,5,6,7-tetrahydrofuro[3,4-c]pyridin-1(3H)-one化学式
CAS
1443251-03-3
化学式
C26H26N2O5
mdl
——
分子量
446.503
InChiKey
LIDICOFSPIKLND-OUKQBFOZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    33
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    92.4
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • COMPOSITION AND METHOD FOR NEUROPEPTIDE S RECEPTOR (NPSR) ANTAGONISTS
    申请人:RESEARCH TRIANGLE INSTITUTE
    公开号:US20150057268A1
    公开(公告)日:2015-02-26
    Neuropeptide S receptor antagonists are provided that bind in functional assays to neuropeptide S receptors; methods are provided for use of these antagonists in treatment of conditions or disease states that are ameliorated by blocking of the neuropeptide S receptor, including substance abuse and substance abuse relapse; and for use of neuropeptide S receptor antagonists in the manufacture of therapeutics and pro-drugs for therapeutics useful in disease states and conditions sensitive to binding of the neuropeptide S receptor.
    本发明提供了与神经肽S受体在功能测定中结合的神经肽S受体拮抗剂;提供了使用这些拮抗剂治疗通过阻断神经肽S受体而改善的疾病状态或疾病的方法,包括物质滥用和物质滥用复发;以及使用神经肽S受体拮抗剂制造治疗剂和治疗剂的前药,对于疾病状态和对神经肽S受体结合敏感的情况有用。
  • Composition and method for neuropeptide S receptor (NPSR) antagonists
    申请人:RESEARCH TRIANGLE INSTITUTE
    公开号:US09150582B2
    公开(公告)日:2015-10-06
    Neuropeptide S receptor antagonists are provided that bind in functional assays to neuropeptide S receptors; methods are provided for use of these antagonists in treatment of conditions or disease states that are ameliorated by blocking of the neuropeptide S receptor, including substance abuse and substance abuse relapse; and for use of neuropeptide S receptor antagonists in the manufacture of therapeutics and pro-drugs for therapeutics useful in disease states and conditions sensitive to binding of the neuropeptide S receptor.
    本发明提供了神经肽S受体拮抗剂,它们在功能性实验中与神经肽S受体结合;提供了使用这些拮抗剂治疗通过阻断神经肽S受体改善的疾病状态或疾病的方法,包括物质滥用和物质滥用复发;以及使用神经肽S受体拮抗剂制造治疗剂和治疗剂的前药,用于治疗对神经肽S受体结合敏感的疾病状态和疾病。
  • US9150582B2
    申请人:——
    公开号:US9150582B2
    公开(公告)日:2015-10-06
查看更多